Breathing in viruses to treat lung infection in ventilated patients
Part of Infections clinical trials.
This trial tests whether breathing in special viruses (called phages) that attack the Pseudomonas bacteria can help clear a serious lung infection in patients on ventilators. The treatment is added to standard antibiotics and may help fight the infection better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are currently on a breathing machine (ventilator) in the intensive care unit
- You have a lung infection caused by a bacteria called Pseudomonas aeruginosa
- You are expected to stay on the ventilator for at least 3 more days
- You must be able to receive treatment through a nebulizer (a machine that turns medicine into a mist to breathe in)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
This trial tests a treatment that uses special viruses (called phages) to kill antibiotic-resistant bacteria causing pneumonia in people on ventilators. If you're eligible, this new approach might help fight the infection when standard antibiotics aren't working well.
This trial tests whether using a rapid test to find the exact bacteria causing your pneumonia can help doctors choose the right antibiotics faster, which might improve your recovery. The study compares this approach to usual care in patients on ventilators.
This trial tests a new treatment using phages (viruses that kill bacteria) for people with cystic fibrosis who have a chronic pseudomonas lung infection. It aims to see if adding phages to your usual care can help control the infection.
This study tests a new treatment that combines regular antibiotics with a special virus that attacks bacteria (called a phage) to fight lung infections that do not respond to standard antibiotics. It aims to see if this combination is safe and might help people with cystic fibrosis who have stubborn lung infections.
This study tests whether giving inhaled antibiotics based on a patient's own airway bacteria can prevent ventilator-associated pneumonia (a lung infection from the breathing tube) in intensive care patients. It may help reduce infections in people who need a breathing tube for more than three days.
Hear when a new Pseudomonas Aeruginosa Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.